Optimizing a Mobile Mindfulness Intervention for ICU Survivors
LIFT2
Optimizing a Self-directed Mobile Mindfulness Intervention for Improving Cardiorespiratory Failure Survivors' Psychological Distress
2 other identifiers
interventional
247
1 country
3
Brief Summary
This is a factorial experimental trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is conceptualized as the Optimization Phase of a multiphase optimization strategy (MOST) framework. This will allow optimization of a mobile mindfulness intervention by comparing eight different iterations across domains including impact on symptoms, feasibility, acceptability, usability, scalability, and cost.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2019
CompletedFirst Posted
Study publicly available on registry
July 31, 2019
CompletedStudy Start
First participant enrolled
August 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 19, 2023
CompletedResults Posted
Study results publicly available
August 15, 2024
CompletedAugust 15, 2024
July 1, 2024
3.7 years
July 24, 2019
April 17, 2024
July 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Health Questionnaire-9 Item Scale (PHQ-9)
Absolute values, not change scores. Depression symptoms. Scores range from 0 (better) to 27 (worse)
1 month post-randomization
Secondary Outcomes (23)
Generalized Anxiety Disorder 7-item Scale (GAD-7)
Between baseline 1 month post-randomization
Patient Health Questionnaire-9 Item Scale (PHQ-9)
Between baseline 3 months post-randomization
Generalized Anxiety Disorder 7-item Scale (GAD-7)
Between baseline 3 months post-randomization
Post-Traumatic Stress Symptom Inventory (PTSS)
Between baseline 3 months post-randomization
Intervention Adherence: Activity in App During Final Week of Intervention
1 month post-randomization
- +18 more secondary outcomes
Study Arms (6)
App introduction to intervention
OTHERIntroduction to intervention via the mobile app itself.
Therapist introduction to intervention
OTHERIntroduction to intervention via a call from the study therapist.
Standard dose
OTHERStandard dose of meditation time (once a day).
High dose
OTHERHigh dose of meditation time (twice a day).
App response to symptoms
OTHERMobile app response to elevated psychological distress symptoms during intervention period.
Therapist response to symptoms
OTHERTherapist call in response to elevated psychological distress symptoms during intervention period.
Interventions
The intervention core is a mobile app-based mindfulness training program designed to be used over a 1-month period. All 6 factorial groups will use the app, though the delivery of the app and response to psychological distress symptoms over time will differ by group.
Eligibility Criteria
You may qualify if:
- Adult (age ≥18)
- Acute cardiorespiratory failure:
- Acute respiratory failure, defined as ≥1 of the following:
- mechanical ventilation via endotracheal tube for ≥12 hours
- non-invasive ventilation (CPAP, BiPAP) for ≥4 hours in a 24-hour period provided for acute respiratory failure in an ICU (not for obstructive sleep apnea or other stable use)
- high flow nasal cannula or face mask oxygen for ≥4 hours in a 24-hour period and / or
- Acute cardiac / circulatory failure, defined as ≥1 of the following:
- use of vasopressors for shock of any etiology for ≥1 hour
- use of inotropes for shock of any etiology for ≥1 hour
- use of pulmonary vascular vasoactive medications
- use of aortic balloon pump for cardiogenic shock for ≥1 hour
- Cognitive status intact
- No history of pre-existing significant cognitive impairment (e.g., dementia) as per medical chart
- Absence of current significant cognitive impairment (impairment defined as ≥3 errors on the Callahan cognitive status screen)
- Decisional capacity present
- +5 more criteria
You may not qualify if:
- Hospitalized within the preceding 3 months with life-threatening illness or injury.
- Patients may be enrolled into the study if they had a hospitalization within the preceding 3 months that is determined to be non-serious. Non-serious admissions are defined as those admissions that are non-life threatening and/or potentially impacting patient's well-being long-term or likely to precipitate additional future admissions. Examples of non-life-threatening hospitalizations could be, but may not be limited to, admission for a bronchoscopy, admission for deep vein thrombosis, or admission to ED resulting in overnight stay for cardiac work-up.
- Admitted from a location other than home (e.g., nursing home, long-term acute care facility, inpatient rehabilitation facility)
- Anticipated or actual discharge to a location other than independent in a home setting (e.g., nursing home, long-term acute care facility, inpatient rehabilitation facility, home hospice)
- Complex medical care expected soon after discharge (e.g., planned surgeries, transplantation evaluation, extensive travel needs for hemodialysis, disruptive chemotherapy/radiation regimen)
- Unable to complete study procedures as determined by staff
- Lack of reliable smartphone with cellular data plan or wifi access
- Low baseline psychological distress symptoms, defined as the absence of the following at T1: PHQ-9 score \<5
- Failure to randomize within 2 month (60 days) post-discharge.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- University of Washingtoncollaborator
- University of Colorado, Denvercollaborator
- National Center for Complementary and Integrative Health (NCCIH)collaborator
Study Sites (3)
University of Colorado - Denver
Aurora, Colorado, 80045, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
University of Washington
Seattle, Washington, 98195, United States
Related Publications (4)
Cox CE, Porter LS, Buck PJ, Hoffa M, Jones D, Walton B, Hough CL, Greeson JM. Development and preliminary evaluation of a telephone-based mindfulness training intervention for survivors of critical illness. Ann Am Thorac Soc. 2014 Feb;11(2):173-81. doi: 10.1513/AnnalsATS.201308-283OC.
PMID: 24303911BACKGROUNDCox CE, Hough CL, Jones DM, Ungar A, Reagan W, Key MD, Gremore T, Olsen MK, Sanders L, Greeson JM, Porter LS. Effects of mindfulness training programmes delivered by a self-directed mobile app and by telephone compared with an education programme for survivors of critical illness: a pilot randomised clinical trial. Thorax. 2019 Jan;74(1):33-42. doi: 10.1136/thoraxjnl-2017-211264. Epub 2018 May 23.
PMID: 29793970BACKGROUNDCox CE, Olsen MK, Gallis JA, Porter LS, Greeson JM, Gremore T, Frear A, Ungar A, McKeehan J, McDowell B, McDaniel H, Moss M, Hough CL. Optimizing a self-directed mobile mindfulness intervention for improving cardiorespiratory failure survivors' psychological distress (LIFT2): Design and rationale of a randomized factorial experimental clinical trial. Contemp Clin Trials. 2020 Sep;96:106119. doi: 10.1016/j.cct.2020.106119. Epub 2020 Aug 15.
PMID: 32805434BACKGROUNDCox CE, Gallis JA, Olsen MK, Porter LS, Gremore T, Greeson JM, Morris C, Moss M, Hough CL. Mobile Mindfulness Intervention for Psychological Distress Among Intensive Care Unit Survivors: A Randomized Clinical Trial. JAMA Intern Med. 2024 Jul 1;184(7):749-759. doi: 10.1001/jamainternmed.2024.0823.
PMID: 38805199DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Christopher Cox
- Organization
- Duke University
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher E Cox, MD
Duke University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- PIs and analysts blinded to allocation. Outcomes completed by participants using web-based interface and thus outcomes assessors as such are blinded.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2019
First Posted
July 31, 2019
Study Start
August 15, 2019
Primary Completion
May 1, 2023
Study Completion
July 19, 2023
Last Updated
August 15, 2024
Results First Posted
August 15, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- We will follow NIH and institutional guidelines.
- Access Criteria
- We will follow NIH and institutional guidelines. Given the length of time that will elapse during the study, we will need to adhere to the rules present at that time.
We will follow NIH/NCCIH guidelines for data access.